Sanofi-Aventis announced recently the results of a study that demonstrated that patients using Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals reported improved patient reported outcomes and decreased glycemic variability versus patients treated with premix analog insulin.

» Continue Reading

Related terms:

• glargine glulisine
• Glargine 2012
• glulisine to glargine
• Glulisine Glargine
• insuline glargine glulisine
• insulin glargine rdna origin ppt
• davidson glulisine
• ORIGIN homepage glargine ppt
• insuline glargine versus insulin
• sanofi aventis basal bolus regime
• insulina sanofi aventis 2011
• insulina glulisina pret
• insulina basal e bolus ptt
• sanofi aventis philippines insulin apidra
• what is the IU conversion for insuline glulisine
• insulin sanofi aventis lantus apidra insuman
• insuline glulisine
• is glargine insulin the same as glulisine insuline
• origin Glargine ppt
• OPAL and glargine and glulisine